Trials / Terminated
TerminatedNCT01101945
Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus
An Open Label, Multi-Center, Long-Term Follow-up Study to Evaluate the Safety of PHX1149T in Subjects With Type 2 Diabetes Mellitus - Extension to Protocol PHX1149-PROT202
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 339 (actual)
- Sponsor
- Phenomix · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate that dutogliptin/PHX1149T is safe and tolerable.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dutogliptin | 400 mg QD |
Timeline
- Start date
- 2007-07-01
- Primary completion
- 2010-01-01
- Completion
- 2010-03-01
- First posted
- 2010-04-12
- Last updated
- 2010-08-11
Locations
55 sites across 5 countries: United States, Argentina, Canada, India, Mexico
Source: ClinicalTrials.gov record NCT01101945. Inclusion in this directory is not an endorsement.